company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,175049000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,175049000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,175049000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4001000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13814000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17815000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,157234000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,38000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2138000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2114000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,159348000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,159348000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,159348000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,159348000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110290000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.44
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116079000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.35
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,110700000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:30:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.44
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1242000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1242000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1242000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3670000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13168000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16838000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15596000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,52000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4781000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4804000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20400000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20400000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20400000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20400000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110810000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110810000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4854000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14574000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19428000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19372000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,60000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18572000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18577000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37949000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37949000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37949000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37949000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,130900000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,130900000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,128998000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6152000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18754000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24906000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24840000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,63000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22903000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22922000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47762000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47762000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47762000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47762000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132700000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132700000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,132021000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25101000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25101000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25101000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6329000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19692000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26021000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-920000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,49000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14846000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14830000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13910000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13910000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13910000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13910000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132587000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,137480000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,139100000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:01:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,77000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,77000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,77000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7045000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24723000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31768000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31691000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,60000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20086000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20111000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-51802000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51802000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51802000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-51802000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132900000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132900000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,132375000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,81000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,81000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11288000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28774000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40062000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-39981000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,57000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15924000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15913000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-55894000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55894000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55894000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55894000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,159700000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,159700000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,160970000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:32:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,318000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,318000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,318000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12224000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39425000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51649000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-51331000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,50000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,69000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,19000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-51312000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51312000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51312000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-51312000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,165500000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,165500000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,165848000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 16:31:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,85000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,85000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14482000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38822000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53304000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-53219000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,47000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-53213000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53213000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53213000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-53213000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,166300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,166300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,166296000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:34:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,74000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,74000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,74000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22915000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37688000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60603000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-60529000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,45000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,50000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,71000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,76000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60453000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60453000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60453000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-60453000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,164800000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,164800000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,164964000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6464000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6464000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,269000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,269000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6195000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29481000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41263000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70744000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-64549000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-70000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-62000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-64611000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,59000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64670000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64670000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-64670000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,179600000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,179600000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,178541000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14011000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14011000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,228000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,228000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13783000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42101000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40668000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,82769000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-68986000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,95000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,87000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-68899000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,86000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-68985000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-68985000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-68985000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,186400000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,186400000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,184726000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:32:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16732000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16732000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,415000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,415000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16317000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37395000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45145000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,82540000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-66223000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-66229000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,110000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66339000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66339000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-66339000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,184300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,184300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,185238000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:34:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8354000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8354000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8700000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8700000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-346000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37638000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35824000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73462000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-73808000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,36000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-146000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-172000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-73980000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,184000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74164000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74164000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-74164000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,184000000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,184000000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,183575000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11782000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11782000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1288000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1288000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10494000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31591000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28554000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60145000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-49651000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,33000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-41000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-52000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-49703000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,119000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49822000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49822000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-49822000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,184500000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,184500000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,186252000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12114000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12114000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2395000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2395000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9719000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34199000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31794000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65993000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56274000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,558000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-541000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-56815000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,106000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56921000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56921000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-56921000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,189700000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,189700000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,186815000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:40:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14682000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14682000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,594000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,594000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14088000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33622000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27600000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61222000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47134000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3720000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,881000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2820000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-49954000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,154000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50108000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50108000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50108000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,185600000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,185600000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,187034000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:51:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66834000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66834000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,947000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,947000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,65887000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40378000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32645000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73023000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7136000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3764000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5377000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1636000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5500000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,251000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5751000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5751000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5751000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,186900000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,186900000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,186835000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23991000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23991000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,695000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,695000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23296000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33550000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39444000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72994000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-49698000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3856000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1073000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2764000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-52462000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,214000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-52676000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-52676000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-52676000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,188100000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,188100000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,187837000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29238000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29238000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,488000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,488000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28750000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48622000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38739000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,87361000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-58611000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3813000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-458000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4249000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-62860000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63160000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63160000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-63160000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,188598000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,188598000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,191400000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:57:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29070000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29070000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,483000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,483000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28587000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36744000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48219000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,84963000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56376000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5228000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,291000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4917000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61293000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5842000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55451000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55451000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55451000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,188921000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,188921000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,191200000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:32:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36505000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36505000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,448000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,448000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36057000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43834000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44814000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,88648000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-52591000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5252000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-113000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5344000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-57935000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1934000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59869000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59869000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59869000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,187900000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,187900000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,188669000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35597000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35597000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,486000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,486000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35111000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35977000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44079000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2918000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,82974000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47863000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4946000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-750000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5672000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-53535000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,252000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53787000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53787000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-53787000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,192100000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,192100000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,190304000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,68125000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,68125000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1108000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1108000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,67017000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34242000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42864000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1482000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,92000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78680000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11663000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5401000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,128635000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,123265000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,111602000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1754000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,109848000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,109848000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,109848000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,191485000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,194569000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,192700000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,2016-08-08 16:57:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46016000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46016000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1131000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1131000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44885000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26249000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43626000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69875000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24990000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8420000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,204000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3045000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5171000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30161000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2334000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27827000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27827000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27827000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,193225000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,193225000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,198800000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,2016-11-08 17:32:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
